S. Sebelius, K. J. Szabó
FULL PAPER
solved in DMSO (0.7 mL). Thereafter, the allylic substrate 2a–f
(0.12 mmol) was added. This reaction mixture was stirred for
10 min at room temperature under Ar. After addition of diboron
reagent 1b (0.12 mmol) the reaction mixture was stirred until a
clear yellow solution was obtained. Thereafter, toluene (0.7 mL)
was added and the reaction mixture was stirred for the allotted
temperatures and times listed in Table 1. Subsequently, the reaction
mixture was diluted with water (1 mL) and stirred for one hour at
room temperature, then the solution was extracted with diethyl
ether (4×2 mL), and the combined ether phases was dried with
MgSO4 and the solvents evaporated. The products 5a–m were iso-
lated by column chromatography using a pentane/EtOAc eluent.
(d, J = 17.3 Hz, 1 H, trans), 4.90 (d, J = 3.7 Hz, 1 H), 4.32 (dd, J
= 11.2 Hz, 7.7 Hz, 1 H), 4.02 (dd, J = 11.2 Hz, 6.1 Hz, 1 H), 2.7
(m, 1 H), 2.66 (s, 1 H, OH), 2.08 (s, 3 H) ppm. 13C NMR (CDCl3):
δ = 171.7, 149.8, 147.7, 132.8, 127.4, 123.8, 120.9, 72.2, 64.6, 51.1,
21.2 ppm.
1-Phenylbut-3-en-1-ol [(R)-5h]: This product was obtained by gene-
ral procedure B. The NMR spectroscopic data are in agreement
with the literature values.[35] Optical rotation: [α]2D0 = +24.0 (c =
0.67, benzene) for 45% ee; ref.[35] [α]2D0 = +51.2 (benzene) for 97%
ee.
2-Methyl-1-phenylbut-3-en-1-ol [(R)-5i]: General procedure B was
employed to obtain the enantiomerically enriched product (R)-5i.
The NMR spectrum is identical with that reported in the litera-
ture.[38] Optical rotation: [α]2D0 = +57.0 (c = 0.46, CHCl3) for 33%
ee; ref.[39] [α]2D0 = +92.0 (CHCl3) for 97% ee.
1-(4-Nitrophenyl)but-3-en-1-ol [5a, (R)-5a and (S)-5a]: General pro-
cedure A was employed for synthesis of the racemic product 5a.
The NMR spectroscopic data obtained of this product is in agree-
ment with the literature values.[34,35] The enantiomerically enriched
product (R)-5a was obtained using general procedure B. Optical
1,2-Diphenylbut-3-en-1-ol [(R)-5j]: General procedure B was em-
ployed to obtain this product. The NMR spectrum is identical with
that reported in the literature.[40] Optical rotation: [α]2D0 = +5.5 (c
= 0.74, CHCl3) for 43% ee; ref.[40] given for the enantiomer form,
(1S,2R)-1,2-diphenylbut-3-en-1-ol, [α]2D0 = –12.5 (CHCl3) for 97.4%
ee.
rotation: [α]2D0 = +14.1 (c = 0.92, C6H6) for 53% ee; ref.[35] [α]2D0
=
+21.5 (C6H6) for 81% ee. The same reaction (according to general
procedure B) was performed with l-tartrate 1c to afford the enan-
tiomerically enriched product (S)-5a. Optical rotation: [α]2D0 = –28.0
(c = 0.67, CHCl3) for 49% ee; ref.[36] [α]2D0 = –33.2 (CHCl3) for 65%
ee.
1-[Hydroxy(phenyl)methyl]allyl Acetate [(S)-5k]: This product was
2-Methyl-1-(4-nitrophenyl)but-3-en-1-ol [(R)-5b and (R)-5b]: Gene-
ral procedure A was employed for synthesis of the racemic product.
The NMR spectroscopic data obtained of this product is in agree-
ment with the literature values.[37] General procedure B was em-
ployed to obtain the enantiomerically enriched product (R)-5b. Op-
tical rotation: [α]2D0 = +23.0 (c = 0.54, CHCl3) for 34% ee. The
configuration was assigned on the basis of the optical rotation data
reported for the parent compound (R)-5i (see below).
obtained by general procedure B. The NMR spectrum is identical
with that reported in the literature.[41] Optical rotation: [α]2D0
=
+19.7 (c = 0.23, CHCl3) for 45% ee. Determination of the configu-
ration is based on the optical rotation data published[42] for
(1S,2R)-(+)-1-phenylbut-3-ene-1,2-diol which was obtained by hy-
drolysis of (S)-5k.
1-(Cyclohexyl)but-3-en-1-ol [(R)-5l]: This product was obtained by
general procedure B. The NMR spectrum is identical with that re-
ported in the literature.[43,44] Optical rotation: [α]2D0 = +3.0 (c =
0.68, EtOH) for 48% ee; ref.[44] [α]2D0 = +9.7 (EtOH) for 98% ee.
1-(4-Nitrophenyl)-2-phenylbut-3-en-1-ol (5c): General procedure A
was employed for synthesis of the racemic product. The NMR
spectrum is in agreement with the literature data.[18]
1-Cyclohexyl-2-phenylbut-3-en-1-ol [(S)-5m]: This product was ob-
tained by general procedure B. The NMR spectrum is identical
with that reported in the literature.[45] [α]2D0 = +42.2 (c = 0.36,
CHCl3) for 53% ee. The configuration was assigned on the basis
of the optical rotation data reported for the phenyl analog (R)-5j
(see above).
Ethyl 2-[Hydroxy(4-nitrophenyl)methyl]but-3-enoate (5d): General
procedure A was employed for synthesis of this product. The NMR
spectrum is identical with that reported in the literature.[18]
2-[Hydroxy(4-nitrophenyl)methyl]but-3-enamide (5e): General pro-
cedure A was employed for synthesis of the racemic product. The
NMR spectrum is identical with that reported in the literature.[18]
N-(1-Phenylbut-3-enyl)benzenesulfonamide (6a): Both procedures
(A and B) gave racemic products. The NMR spectrum is identical
with that reported in the literature.[33]
1-[Hydroxy(4-nitrophenyl)methyl]allyl Acetate [5f[8] and (S)-5f]: Ge-
neral procedure A was employed for synthesis of the racemic pro-
duct. The crude product was purified by silica gel chromatography
N-(1,2-Diphenylbut-3-enyl)benzenesulfonamide (6b): General pro-
cedure A was employed for synthesis of this product. The NMR
spectrum is identical with that reported in the literature.[18]
1
using pentane/ethyl acetate (4:1) as eluent. H NMR (CDCl3): δ =
8.22 (d, J = 8.8 Hz, 2 H), 7.56 (d, J = 8.8 Hz, 2 H), 5.76 (ddd, J =
6.6 Hz, 10.4 Hz, 17.2 Hz, 1 H), 5.45 (dd, J = 6.6 Hz, 3.9 Hz, 1 H),
5.31 (d, J = 10.4 Hz, 1 H, cis), 5.26 (d, J = 17.2 Hz, 1 H, trans),
5.01 (t, J = 3.9 Hz, 1 H), 2.54 (d, J = 3.7 Hz, 1 H, OH) 2.09 (s, 3
H) ppm. 13C NMR (CDCl3): δ = 170.3, 146.8, 131.1, 128.8, 127.8,
123.8, 121.0, 78.3, 74.6, 21.4 ppm. General procedure B was em-
ployed to obtain the enantiomerically enriched product (S)-5f. Op-
tical rotation: [α]2D0 = +27.8 (c = 0.39, CHCl3) for 50% ee. The
configuration was assigned on the basis of the optical rotation data
reported for the hydrolysis product of the parent compound (S)-5k
(see below).
Ethyl 2-[Phenylsulfonylamino(phenyl)methyl]but-3-enoate (6c): Ge-
neral procedure A was employed for synthesis of this product. The
NMR spectrum is identical with that reported in the literature.[18]
2-[Phenylsulfonylamino(phenyl)methyl]but-3-enamide (6d):[8] This
product was obtained by general procedure B. The crude product
was purified by silica gel chromatography using dichloromethane/
methanol (20:1) as eluent. 1H NMR ([D6]DMSO): δ = 8.28 (d, J =
9.4 Hz, 1 H, NH), 7.48 (d, J = 7.4 Hz, 2 H), 7.39 (t, J = 7.4 Hz, 1
H), 7.26 (t, J = 7.4 Hz, 2 H), 7.04 (m, 5 H), 5.69 (ddd, J = 10.2 Hz,
10.0 Hz, 17.1 Hz, 1 H, anti), 5.51 (ddd, J = 9.4 Hz, 10.2 Hz,
17.2 Hz, 1 H, syn), 5.22 (d, J = 17.1 Hz, 1 H, trans, anti), 5.08 (d,
J = 10.0 Hz, 1 H, cis, anti), 4.84 (d, J = 17.2 Hz, 1 H, trans, syn),
4.80 (d, J = 10.2 Hz, 1 H, cis, syn), 4.68 (t, J = 9.4 Hz, 1 H, syn),
4.55 (t, J = 10.2 Hz, 1 H, anti), 3.28 (t, J = 10.2 Hz, 1 H, anti),
3.17 (t, J = 9.4 Hz, 1 H, syn) ppm. 13C NMR ([D6]DMSO): δ =
2-[Hydroxy(4-nitrophenyl)methyl]but-3-enyl Acetate (5g):[8] General
procedure A was employed for preparation of the racemic product.
The crude product was purified by silica gel chromatography using
1
pentane/diethyl ether (2:1) as eluent. H NMR (CDCl3): δ = 8.20
(d, J = 8.8 Hz, 2 H), 7.50 (d, J = 8.8 Hz, 2 H), 5.70 (ddd, J =
8.5 Hz, 10.4 Hz, 17.3 Hz, 1 H), 5.19 (d, J = 10.4 Hz, 1 H, cis), 5.04
2546
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 2539–2547